Fulcrum Therapeutics, Inc. (FULC)
3.855
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
3.855
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Market Cap : 294.08M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 293.70M |
| August 26, 2026 | 294.46M |
| August 25, 2026 | 294.46M |
| August 24, 2026 | 292.94M |
| August 21, 2026 | 292.17M |
| August 20, 2026 | 293.70M |
| August 19, 2026 | 298.28M |
| August 18, 2026 | 295.22M |
| August 17, 2026 | 292.94M |
| August 14, 2026 | 285.31M |
| August 13, 2026 | 283.02M |
| August 12, 2026 | 283.78M |
| August 11, 2026 | 281.49M |
| August 10, 2026 | 286.07M |
| August 07, 2026 | 296.75M |
| August 06, 2026 | 287.60M |
| August 05, 2026 | 287.60M |
| August 04, 2026 | 289.88M |
| August 03, 2026 | 283.02M |
| July 31, 2026 | 273.10M |
| July 30, 2026 | 283.78M |
| July 29, 2026 | 276.15M |
| July 28, 2026 | 283.78M |
| July 27, 2026 | 248.45M |
| July 24, 2026 | 247.78M |
| Date | Value |
|---|---|
| July 23, 2026 | 250.45M |
| July 22, 2026 | 246.45M |
| July 21, 2026 | 245.12M |
| July 20, 2026 | 241.12M |
| July 17, 2026 | 243.12M |
| July 16, 2026 | 233.13M |
| July 15, 2026 | 237.12M |
| July 14, 2026 | 239.12M |
| July 13, 2026 | 235.79M |
| July 10, 2026 | 233.13M |
| July 09, 2026 | 239.12M |
| July 08, 2026 | 248.45M |
| July 07, 2026 | 251.11M |
| July 06, 2026 | 247.78M |
| July 02, 2026 | 255.78M |
| July 01, 2026 | 242.45M |
| June 30, 2026 | 243.79M |
| June 29, 2026 | 248.45M |
| June 26, 2026 | 253.11M |
| June 25, 2026 | 240.46M |
| June 24, 2026 | 250.45M |
| June 23, 2026 | 256.44M |
| June 22, 2026 | 251.11M |
| June 18, 2026 | 246.45M |
| June 17, 2026 | 233.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.31M |
| CNBX Pharmaceuticals, Inc. | 0.2066M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 598.80M |
| Definium Therapeutics, Inc. | 5.505B |
Market Cap Related Metrics
| Price to Book Value | 0.9465 |
| Price | 3.855 |
| Earnings Yield | -31.47% |